Market Research Logo

Prurigo Nodularis Treatment Market: Western Europe Projected to be the Most Attractive Regional Market: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028

Prurigo Nodularis Treatment Market: Western Europe Projected to be the Most Attractive Regional Market: Global Industry Analysis 2013 - 2017 and Opportunity Assessment 2018 - 2028

This Future Market Insights report examines the ‘Prurigo Nodularis Treatment Market’ for the period 2013–2017 and provides forecast for 2018–2028. The primary objective of the report is to offer updates and in-depth analysis of market opportunities in the global Prurigo Nodularis Treatment Market.

Globally, the increasing demand for Prurigo Nodularis treatment, for the treatment of rare diseases is anticipated to drive the growth prurigo nodularis treatment market over the forecast period. Increasing government spending on healthcare infrastructure such as favourable reimbursement for prurigo nodularis treatment is expected to boost growth of the global prurigo nodularis treatment market. The growing research initiatives for prurigo nodularis treatment with the help of non-profit organizations and increasing government support further fuel the growth of the Prurigo Nodularis Treatment Market.

However, availability of alternative treatment options and high treatment cost are the factors which are expected to hamper the growth of the global prurigo nodularis treatment market. Dearth of skilled healthcare professionals and lack of regulatory framework in emerging economics may further hinder the growth of the global Prurigo Nodularis Treatment Market over the forecast period.

Global Prurigo Nodularis Treatment Market has been segmented on the basis of:

Product Type

Distribution Channel

Region

The report analyses global Prurigo Nodularis Treatment Market in terms of value (US$ Mn). Report begins with the market definition and explaining different product types which fall und prurigo nodularis treatment. The market view point section includes FMI’s analysis on key trends, drivers, restraints, opportunities and macro factors influencing global market for prurigo nodularis treatment. Opportunity analysis provided in the section allows client to better equip clients with crystal clear decision making insights.

The report analyses market based on regions and presents the forecast in terms of value for the next 10 years for prurigo nodularis treatment. Regions covered in the report include:

North America

Latin America

Western Europe

Eastern Europe

Asia Pacific Excluding China and Japan (APECJ)

China

Japan

Middle East and Africa (MEA)

Each of these section analyses regional market by product type, distribution channel, and country for prurigo nodularis treatment. Regional market dynamics section provides key growth trends pertaining to each region. Representative market participants section gives list of companies operating in every region, competitive landscape and intensity map of their presence in each region.

Weighted average selling price is considered to estimate the market size of various devices mentioned in the scope of the study. The country price is captured with the local currency. The local currency figures is then converted to USD to offer forecasts in a consistent currency standard. Furthermore, FMI also considered the latest annual exchange rate to reflect the impact of the most recent economic conditions of country. Prices considered in the models are standardized based on the average cost for Prurigo Nodularis treatment.

The forecast for prurigo nodularis treatment market presented in the report provides total revenue of Prurigo Nodularis treatment over 2018–2028. In addition, we have taken into consideration the year-on-year growth to understand the predictability of the market and to identify the right growth opportunities in the global market.

In the next section of the report, the ‘Competitive Landscape’ is included to provide report to the audiences with a dashboard view and to access the key differentiators among the competitor firms. This section is primarily designed to provide clients with an objective and detailed comparative assessment of product offerings and strategies of key providers specific to a market segments. Detailed profiles of players in Prurigo Nodularis Treatment Market are also provided in the report which highlights company description, overview, product/segment overview, SWOT analysis, financial information, key developments related to market and strategic overview.

The next section of report analyses the market based on product type and presents the forecast in terms of value for the next 10 years. Prurigo Nodularis treatment product type covered in the report include:

Corticosteroids

Injectable

Topical

Oral

Emollients

Capsacin Cream

Antihistamines

Others

The next section of report analyses the market based on distribution channel of the Prurigo Nodularis treatment and provides forecast in terms of value for the next 10 years. On the basis of distribution channel, the Prurigo Nodularis Treatment Market is segmented into:

Hospital Pharmacies

Retail Pharmacies

Online Pharmacies

Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective of the products. To understand key growth segments, Future Market Insights provides the ‘Attractiveness Index’ analysis which helps client to identify real market opportunities.


1. Executive Summary
1.1. Market Overview
1.2. Market Analysis
1.3. FMI Analysis and Recommendations
1.4. Wheel of Fortune
2. Market Introduction
2.1. Market Taxonomy
2.2. Market Definition
3. Prurigo Nodularis Product Type And Management Market View Point
3.1. Macro-Economic Factors
3.2. Opportunity Analysis
3.3. Drivers
3.4. Restraints
3.5. Trends
4. Macroeconomic Assumptions
5. Global Economic Outlook
5.1. Expenditure on Health By Country, 2016-2021
5.2. Global Healthcare Market Outlook
6. North America Prurigo Nodularis Product Type And Management Market Analysis 2013-2017and Forecast 2017-2028
6.1. Introduction
6.2. Historical Market Size (US$ Mn) By Country, 2013-2017
6.2.1. U.S.
6.2.2. Canada
6.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
6.3.1. U.S.
6.3.2. Canada
6.4. Historical Market Size (US$ Mn) By Product Type, 2013-2017
6.4.1. Corticosteroids
6.4.1.1. Injectable
6.4.1.2. Topical
6.4.1.3. Oral
6.4.2. Emollients
6.4.3. Capsaicin Cream
6.4.4. Antihistamines
6.4.5. Others
6.5. Market Size (US$ Mn) Forecast By Product Type, 2018-2028
6.5.1. Corticosteroids
6.5.1.1. Injectable
6.5.1.2. Topical
6.5.1.3. Oral
6.5.2. Emollients
6.5.3. Capsaicin Cream
6.5.4. Antihistamines
6.5.5. Others
6.6. Others Historical Market Size (US$ Mn) By Distribution Channels, 2013-2017
6.6.1. Hospital Pharmacies
6.6.2. Retail Pharmacies
6.6.3. Online pharmacies
6.7. Market Size (US$ Mn) Forecast By Distribution Channels, 2018-2028
6.7.1. Hospital Pharmacies
6.7.2. Retail Pharmacies
6.7.3. Online pharmacies
6.8. Market Attractiveness Analysis
6.8.1. By Country
6.8.2. By Product Type
6.8.3. By Distribution Channels
7. Latin America Prurigo Nodularis Product Type And Management Market Analysis 2013-2017and Forecast 2017-2028
7.1. Introduction
7.2. Historical Market Size (US$ Mn) By Country, 2013-2017
7.2.1. Brazil
7.2.2. Mexico
7.2.3. Argentina
7.2.4. Rest of Latin America
7.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
7.3.1. Brazil
7.3.2. Mexico
7.3.3. Argentina
7.3.4. Rest of Latin America
7.4. Historical Market Size (US$ Mn) By Product Type, 2013-2017
7.4.1. Corticosteroids
7.4.1.1. Injectable
7.4.1.2. Topical
7.4.1.3. Oral
7.4.2. Emollients
7.4.3. Capsaicin Cream
7.4.4. Antihistamines
7.4.5. Others
7.5. Market Size (US$ Mn) Forecast By Product Type, 2018-2028
7.5.1. Corticosteroids
7.5.1.1. Injectable
7.5.1.2. Topical
7.5.1.3. Oral
7.5.2. Emollients
7.5.3. Capsaicin Cream
7.5.4. Antihistamines
7.5.5. Others
7.6. Others Historical Market Size (US$ Mn) By Distribution Channels, 2013-2017
7.6.1. Hospital Pharmacies
7.6.2. Retail Pharmacies
7.6.3. Online pharmacies
7.7. Market Size (US$ Mn) Forecast By Distribution Channels, 2018-2028
7.7.1. Hospital Pharmacies
7.7.2. Retail Pharmacies
7.7.3. Online pharmacies
7.8. Market Attractiveness Analysis
7.8.1. By Country
7.8.2. By Product Type
7.8.3. By Distribution Channels
8. Western Europe Prurigo Nodularis Product Type And Management Market Analysis 2013-2017and Forecast 2017-2028
8.1. Introduction
8.2. Historical Market Size (US$ Mn) By Country, 2013-2017
8.2.1. Germany
8.2.2. U.K.
8.2.3. France
8.2.4. Italy
8.2.5. Spain
8.2.6. Rest of Western Europe
8.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
8.3.1. Germany
8.3.2. U.K.
8.3.3. France
8.3.4. Italy
8.3.5. Spain
8.3.6. Rest of Western Europe
8.4. Historical Market Size (US$ Mn) By Product Type, 2013-2017
8.4.1. Corticosteroids
8.4.1.1. Injectable
8.4.1.2. Topical
8.4.1.3. Oral
8.4.2. Emollients
8.4.3. Capsaicin Cream
8.4.4. Antihistamines
8.4.5. Others
8.5. Market Size (US$ Mn) Forecast By Product Type, 2018-2028
8.5.1. Corticosteroids
8.5.1.1. Injectable
8.5.1.2. Topical
8.5.1.3. Oral
8.5.2. Emollients
8.5.3. Capsaicin Cream
8.5.4. Antihistamines
8.5.5. Others
8.6. Others Historical Market Size (US$ Mn) By Distribution Channels, 2013-2017
8.6.1. Hospital Pharmacies
8.6.2. Retail Pharmacies
8.6.3. Online pharmacies
8.7. Market Size (US$ Mn) Forecast By Distribution Channels, 2018-2028
8.7.1. Hospital Pharmacies
8.7.2. Retail Pharmacies
8.7.3. Online pharmacies
8.8. Market Attractiveness Analysis
8.8.1. By Country
8.8.2. By Product Type
8.8.3. By Distribution Channels
9. Eastern Europe Prurigo Nodularis Product Type And Management Market Analysis 2013-2017and Forecast 2017-2028
9.1. Introduction
9.2. Historical Market Size (US$ Mn) By Country, 2013-2017
9.2.1. Russia
9.2.2. Poland
9.2.3. Rest of Eastern Europe
9.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
9.3.1. Russia
9.3.2. Poland
9.3.3. Rest of Eastern Europe
9.4. Historical Market Size (US$ Mn) By Product Type, 2013-2017
9.4.1. Corticosteroids
9.4.1.1. Injectable
9.4.1.2. Topical
9.4.1.3. Oral
9.4.2. Emollients
9.4.3. Capsaicin Cream
9.4.4. Antihistamines
9.4.5. Others
9.5. Market Size (US$ Mn) Forecast By Product Type, 2018-2028
9.5.1. Corticosteroids
9.5.1.1. Injectable
9.5.1.2. Topical
9.5.1.3. Oral
9.5.2. Emollients
9.5.3. Capsaicin Cream
9.5.4. Antihistamines
9.5.5. Others
9.6. Others Historical Market Size (US$ Mn) By Distribution Channels, 2013-2017
9.6.1. Hospital Pharmacies
9.6.2. Retail Pharmacies
9.6.3. Online pharmacies
9.7. Market Size (US$ Mn) Forecast By Distribution Channels, 2018-2028
9.7.1. Hospital Pharmacies
9.7.2. Retail Pharmacies
9.7.3. Online pharmacies
9.8. Market Attractiveness Analysis
9.8.1. By Country
9.8.2. By Product Type
9.8.3. By Distribution Channels
9.8.4. Drivers and Restraints: Impact Analysis
9.9. Market Attractiveness Analysis
9.9.1. By Country
9.9.2. By Product Type
9.9.3. By Distribution Channels
10. Asia Pacific Excluding China and Japan Prurigo Nodularis Product Type And Management Market Analysis 2013-2017and Forecast 2017-2028
10.1. Introduction
10.2. Historical Market Size (US$ Mn) By Country, 2013-2017
10.2.1. India
10.2.2. Australia and New Zealand
10.2.3. ASEAN
10.2.4. Rest of APECJ
10.3. Market Size (US$ Mn) Forecast By Country, 2018-2028
10.3.1. India
10.3.2. Australia and New Zealand
10.3.3. ASEAN
10.3.4. Rest of APECJ
10.4. Historical Market Size (US$ Mn) By Product Type, 2013-2017
10.4.1. Corticosteroids
10.4.1.1. Injectable
10.4.1.2. Topical
10.4.1.3. Oral
10.4.2. Emollients
10.4.3. Capsaicin Cream
10.4.4. Antihistamines
10.4.5. Others
10.5. Market Size (US$ Mn) Forecast By Product Type, 2018-2028
10.5.1. Corticosteroids
10.5.1.1. Injectable
10.5.1.2. Topical
10.5.1.3. Oral
10.5.2. Emollients
10.5.3. Capsaicin Cream
10.5.4. Antihistamines
10.5.5. Others
10.6. Historical Market Size (US$ Mn) By Distribution Channels, 2013-2017
10.6.1. Hospital Pharmacies
10.6.2. Retail Pharmacies
10.6.3. Online pharmacies
10.7. Market Size (US$ Mn) Forecast By Distribution Channels, 2018-2028
10.7.1. Hospital Pharmacies
10.7.2. Retail Pharmacies
10.7.3. Online pharmacies
10.8.Market Attractiveness Analysis
10.8.1. By Country
10.8.2. By Product Type
10.8.3. By Distribution Channels
11. China Prurigo Nodularis Product Type And Management Market Analysis 2013-2017and Forecast 2017-2028
11.1. Introduction
11.2. Historical Market Size (US$ Mn) By Product Type, 2013-2017
11.2.1. Corticosteroids
11.2.1.1. Injectable
11.2.1.2. Topical
11.2.1.3. Oral
11.2.2. Emollients
11.2.3. Capsaicin Cream
11.2.4. Antihistamines
11.2.5. Others
11.3. Market Size (US$ Mn) Forecast By Product Type, 2018-2028
11.3.1. Corticosteroids
11.3.1.1. Injectable
11.3.1.2. Topical
11.3.1.3. Oral
11.3.2. Emollients
11.3.3. Capsaicin Cream
11.3.4. Antihistamines
11.3.5. Others
11.4. Historical Market Size (US$ Mn) By Distribution Channels, 2013-2017
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online pharmacies
11.5. Market Size (US$ Mn) Forecast By Distribution Channels, 2018-2028
11.5.1. Hospital Pharmacies
11.5.2. Retail Pharmacies
11.5.3. Online pharmacies
11.6.Market Attractiveness Analysis
11.6.1. By Product Type
11.6.2. By Distribution Channels
12. Japan Prurigo Nodularis Product Type And Management Market Analysis 2013-2017and Forecast 2017-2028
12.1.Introduction
12.2.Historical Market Size (US$ Mn) By Product Type, 2013-2017
12.2.1. Corticosteroids
12.2.1.1. Injectable
12.2.1.2. Topical
12.2.1.3. Oral
12.2.2. Emollients
12.2.3. Capsaicin Cream
12.2.4. Antihistamines
12.2.5. Others
12.3.Market Size (US$ Mn) Forecast By Product Type, 2018-2028
12.3.1. Corticosteroids
12.3.1.1. Injectable
12.3.1.2. Topical
12.3.1.3. Oral
12.3.2. Emollients
12.3.3. Capsaicin Cream
12.3.4. Antihistamines
12.3.5. Others
12.4.Historical Market Size (US$ Mn) By Distribution Channels, 2013-2017
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online pharmacies
12.5.Market Size (US$ Mn) Forecast By Distribution Channels, 2018-2028
12.5.1. Hospital Pharmacies
12.5.2. Retail Pharmacies
12.5.3. Online pharmacies
12.6.Market Attractiveness Analysis
12.6.1. By Product Type
12.6.2. By Distribution Channels
13. Middle East and Africa Prurigo Nodularis Product Type And Management Market Analysis 2013-2017and Forecast 2017-2028
13.1.Introduction
13.2.Historical Market Size (US$ Mn) By Country, 2013-2017
13.2.1. GCC Countries
13.2.2. South Africa
13.2.3. Rest of Middle East and Africa
13.3.Market Size (US$ Mn) Forecast By Country, 2018-2028
13.3.1. GCC Countries
13.3.2. South Africa
13.3.3. Rest of Middle East and Africa
13.4.Historical Market Size (US$ Mn) By Product Type, 2013-2017
13.4.1. Corticosteroids
13.4.1.1. Injectable
13.4.1.2. Topical
13.4.1.3. Oral
13.4.2. Emollients
13.4.3. Capsaicin Cream
13.4.4. Antihistamines
13.4.5. Others
13.5.Market Size (US$ Mn) Forecast By Product Type, 2018-2028
13.5.1. Corticosteroids
13.5.1.1. Injectable
13.5.1.2. Topical
13.5.1.3. Oral
13.5.2. Emollients
13.5.3. Capsaicin Cream
13.5.4. Antihistamines
13.5.5. Others
13.6.Historical Market Size (US$ Mn) By Distribution Channels, 2013-2017
13.6.1. Hospital Pharmacies
13.6.2. Retail Pharmacies
13.6.3. Online pharmacies
13.7.Market Size (US$ Mn) Forecast By Distribution Channels, 2018-2028
13.7.1. Hospital Pharmacies
13.7.2. Retail Pharmacies
13.7.3. Online pharmacies
13.8.Market Attractiveness Analysis
13.8.1. By Country
13.8.2. By Product Type
13.8.3. By Distribution Channels
14. Forecast Factors: Relevance and Impact
15. Competition Landscape
15.1.Competition Dashboard
15.2.Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
15.2.1. Bayer AG
15.2.2. Pfizer Inc.
15.2.3. GlaxoSmithKline plc.
15.2.4. Teva Pharmaceutical Industries Ltd
15.2.5. Johnson & Johnson Services, Inc.
15.2.6. Merck & Co. Inc.
15.2.7. Sanofi SA
15.2.8. Takeda Pharmaceutical Company Limited
16. Global Prurigo Nodularis Product Type And Management Market Analysis 2013-2017and Forecast 2017-2028 By Region
16.1.Introduction / Key Findings
16.2.Historical Market Size (US$ Mn) By Region
16.2.1. North America
16.2.2. Western Europe
16.2.3. Eastern Europe
16.2.4. Latin America
16.2.5. Asia Pacific Excluding China and Japan
16.2.6. China
16.2.7. Japan
16.2.8. Middle East and Africa
16.3.Market Size (US$ Mn) Forecast By Region
16.3.1. North America
16.3.2. Western Europe
16.3.3. Eastern Europe
16.3.4. Latin America
16.3.5. Asia Pacific Excluding China and Japan
16.3.6. China
16.3.7. Japan
16.3.8. Middle East and Africa
16.4.Market Attractiveness Analysis By Region
17. Global Prurigo Nodularis Product Type And Management Market Analysis 2013-2017and Forecast 2017-2028, By Product Type
17.1.Introduction/Key Finding
17.2.Historical Market Size (US$ Mn) By Product Type, 2013-2017
17.2.1. Corticosteroids
17.2.1.1. Injectable
17.2.1.2. Topical
17.2.1.3. Oral
17.2.2. Emollients
17.2.3. Capsaicin Cream
17.2.4. Antihistamines
17.2.5. Others
17.3.Others Market Size (US$ Mn) Forecast By Product Type, 2018-2028
17.3.1. Corticosteroids
17.3.1.1. Injectable
17.3.1.2. Topical
17.3.1.3. Oral
17.3.2. Emollients
17.3.3. Capsaicin Cream
17.3.4. Antihistamines
17.3.5. Others
17.4.Market Attractiveness Analysis By Product Type
18. Global Prurigo Nodularis Product Type And Management Market Analysis 2013-2017and Forecast 2017-2028, By Distribution Channels
18.1.Introduction/Key Finding
18.2.Historical Market Size (US$ Mn) By Distribution Channels, 2013-2017
18.2.1. Hospital Pharmacies
18.2.2. Retail Pharmacies
18.2.3. Online pharmacies
18.3.Market Size (US$ Mn) Forecast By Distribution Channels, 2018-2028
18.3.1. Hospital Pharmacies
18.3.2. Retail Pharmacies
18.3.3. Online pharmacies
18.4.Market Attractiveness Analysis By Distribution Channels
19. Global Prurigo Nodularis Product Type And Management Market Analysis 2013-2017and Forecast 2017-2028
19.1.Market Size and Y-o-Y Growth
19.2.Absolute $ Opportunity
20. Assumptions and Acronyms Used
21. Research Methodology

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report